CN1359691A - Medicine for treating pulmonery tuberculosis - Google Patents
Medicine for treating pulmonery tuberculosis Download PDFInfo
- Publication number
- CN1359691A CN1359691A CN 00129432 CN00129432A CN1359691A CN 1359691 A CN1359691 A CN 1359691A CN 00129432 CN00129432 CN 00129432 CN 00129432 A CN00129432 A CN 00129432A CN 1359691 A CN1359691 A CN 1359691A
- Authority
- CN
- China
- Prior art keywords
- medicine
- semen
- tuberculosis
- present
- acupuncture point
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 201000008827 tuberculosis Diseases 0.000 title claims abstract description 9
- 229940079593 drug Drugs 0.000 title claims description 12
- 210000000582 semen Anatomy 0.000 claims description 15
- 238000001467 acupuncture Methods 0.000 claims description 9
- 230000001355 anti-mycobacterial effect Effects 0.000 claims description 9
- 239000003926 antimycobacterial agent Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 244000184734 Pyrus japonica Species 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 206010006451 bronchitis Diseases 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 241000489492 Arisaema Species 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- 241001530119 Vaccaria Species 0.000 abstract 1
- 235000013614 black pepper Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000001931 piper nigrum l. white Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
An exterior-applied medicine for treating pulmonery tuberculosis and bronchitis by applying it to Yongquan acupoint is prepared from 5 Chinese-medicinal materials includig arisaema tuber, vaccaria seed, white pepper, etc. Its advantages are high curative effect, and no toxic by-effect.
Description
The present invention is a kind of phthisical medicine that is used for the treatment of, specifically a kind of with Chinese medicine be that raw material is made, be used for the treatment of phthisical medicine, and the using method of this medicine.
Pulmonary tuberculosis is a kind of common infectious disease, and morbidity back PD is fast, it is heavy to invade profit, and is fast by respiratory tract and aerial infection, is often threatening that people's is healthy.The phthisical measure of current treatment is a lot, also can control its infectious disease, but treat phthisical medicine at present, it all is the medicine that extracts by chemical method, these medicines injure patient's liver, kidney, stomach easily, as rifampicin medicine, to liver stimulate, to damage liver bigger, isoniazid damages and does not send nerve, and some other treatment tuberculosis medicine also easily stimulates, stomach.
The objective of the invention is to develop better motherland's natural plants Chinese medicine, exploitation traditional Chinese medicines resource, for society, prevent and cure diseases for the mankind, solve the existing problem and shortage part of current domestic and international treatment pulmonary tuberculosis medicine, a kind of have anti-mycobacterium tuberculosis, relieving cough and resolving phlegm, lung moistening, adjustment body are provided, improve immunity, be aided with the blood circulation promoting and blood stasis dispelling function, need not have an injection, need not take orally, only cooperate the acupuncture point just can treat pulmonary tuberculosis, and the also double medicine of controlling the treating pulmonery tuberculosis of chronic bronchitis.
For realizing purpose of the present invention, the technical scheme of taking is: according to the traditional Chinese medical science pathological study and dialectical the executing of pulmonary tuberculosis are controlled principle, according to the Chinese prescription principle, by anti-mycobacterium tuberculosis, nourishing the lung to arrest cough, adjustment immunity of organisms, it is main being aided with the blood-activating stasis-removing kind medicine, cooperate outside the acupuncture point, reach treatment pulmonary tuberculosis, realization the present invention's purpose.
Pulmonary tuberculosis is called pulmonary tuberculosis in Chinese medicine, be pulmonary infection tubercule bacillus and the chronic expendable infectious disease that causes, clinical manifestation is a main symptom with cough, spitting of blood, hectic fever night sweat, belong to the precise and tiny hypofunction that chronic consumptive disease excessively causes the defeated water distribution paddy of transporting and transforming function of the spleen and stomach, can not biochemical QI and blood, lung loses and makes moist, does condition of disease power and descend, table Wei Bugu, tubercule bacillus is taken advantage of a weak point, due to the respiratory tract invasion lungs, lung tissue is damaged and morbidity.
The present invention is according to four above-mentioned big diseases, uses natural plants Chinese medicine, cooperate outside the acupuncture point, and the treatment pulmonary tuberculosis, and can doublely control bronchitis etc.
Medicine of the present invention by monarch, minister, help, make compatibility.Semen Momordicae, Semen Persicae, Semen Vaccariae, Rhizoma Arisaematis are monarch drug, and Semen Momordicae is slightly poisonous, and treating the poisonous disease with poisonous drugs kills tubercule bacillus, and Semen Persicae, Wang Shi stay row, Rhizoma Arisaematis blood circulation promoting and blood stasis dispelling, eliminate the phlegm, except that dry; Semen Armeniacae Amarum, Radix orixae japonicae belong to ministerial drug, have eliminating phlegm and stopping cough, anastalsis; Oryza glutinosa is assistant, messenger drug, belongs to the tying-in medicine.Therefore, medicament composing prescription of the present invention (by weight) is: 37 of Semen Momordicae, 3～7 in Semen Persicae, Rhizoma Arisaematis 3～7 grams, Semen Vaccariae 3～7 grams, 3～7 in Semen Armeniacae Amarum, 3～7 of Radix orixae japonicaes, 3～7 in Oryza glutinosa.
Using method of the present invention:
With the common porphyrize powder of said medicine, transfer the Ao Yongquan acupuncture point, as can be made into the medicine adhesive plaster and be affixed on and gush the position, changed medicine one time in 12～16 hours, continuous 6～10 times, just can reach therapeutic effect, need not have an injection, also need not take Western medicine orally.
Gushing the warp that a spring cave belongs to kidney, be the well of kidney, is that arteries and veins gas goes out, and the function at this acupuncture point cooperates dirty dry, the pulmonary tuberculosis of curable substance according to the rule of " rushing down its son in fact " and " the dirty well of getting ", adjusts body, gets rid of toxin, suppresses tubercule bacillus, diminishes inflammation.Therefore, transfer medicine of the present invention on the Ao at the spring acupuncture point, continuous 6～10 times, just can reach the phthisical effect of treatment, be the medicine of ideal lungy due to dirty dry, the dirty consumptive disease of treatment.
Have only Semen Momordicae little slightly poisonous in the used medicine of the present invention, no big side effect, because medicine of the present invention is external, therefore, external is safe and reliable.
The present invention is safe and reliable through animal acute and chronic toxicity test proof, and the present invention uses through 268 routine lungers, and effective percentage reaches 98%.Because the present invention executes according to differential diagnosis in tcm to control principle and Chinese prescription principle, by anti-mycobacterium tuberculosis, nourishing the lung to arrest cough, adjust immunity of organisms, it is main being aided with the blood-activating stasis-removing kind medicine, cooperates external outside the spring acupuncture point, pharmaceutical purity platymiscium Chinese medicine, therefore, the present invention has anti-mycobacterium tuberculosis, relieving cough and resolving phlegm, lung moistening, blood circulation promoting and blood stasis dispelling, adjust body, improve the function of immunity, cooperate the spring acupuncture point, can treat pulmonary tuberculosis effectively, and can doublely control bronchitis, its efficacy stability, curative effect height, need not have an injection, need not take orally, easy to use, have no side effect, not impairing the liver, stomach, characteristics such as safe and reliable.For the treatment pulmonary tuberculosis provides a kind of esy to use, safe and reliable, novel antimycobacterial drug of having no side effect.
Claims (2)
1, a kind of antimycobacterial drug based on Chinese medicine is characterized in that the medicament composing prescription (by weight) of said antimycobacterial drug is: 3～7 of Semen Momordicae, 3～7 in Semen Persicae, Rhizoma Arisaematis 3～7 grams, Semen Vaccariae 3～7 grams, 3～7 in Semen Armeniacae Amarum, 3～7 of Radix orixae japonicaes, 3～7 in Oryza glutinosa.
2, the using method of the said antimycobacterial drug of a kind of claim 1 is characterized in that the common porphyrize powder of the used medicine of this treating pulmonery tuberculosis, transfers the Ao Yongquan acupuncture point.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001294326A CN1191839C (en) | 2000-12-20 | 2000-12-20 | Medicine for treating pulmonery tuberculosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001294326A CN1191839C (en) | 2000-12-20 | 2000-12-20 | Medicine for treating pulmonery tuberculosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1359691A true CN1359691A (en) | 2002-07-24 |
| CN1191839C CN1191839C (en) | 2005-03-09 |
Family
ID=4593502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001294326A Expired - Lifetime CN1191839C (en) | 2000-12-20 | 2000-12-20 | Medicine for treating pulmonery tuberculosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1191839C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1320918C (en) * | 2005-08-29 | 2007-06-13 | 焦仕 | Miao medicine for treating tuberculosis and rheumatic heart disease and its compounding process and usage |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101274066B (en) * | 2007-03-30 | 2011-03-16 | 陈实兵 | Chinese medicine composition for tuberculous |
-
2000
- 2000-12-20 CN CNB001294326A patent/CN1191839C/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1320918C (en) * | 2005-08-29 | 2007-06-13 | 焦仕 | Miao medicine for treating tuberculosis and rheumatic heart disease and its compounding process and usage |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1191839C (en) | 2005-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1098317A (en) | Health-care sachet and preparation method thereof | |
| CN1124856C (en) | Pill for treating hemiplegia | |
| CN106038934A (en) | Traditional Chinese medicine disinfectant for acupuncture | |
| CN1191839C (en) | Medicine for treating pulmonery tuberculosis | |
| CN105250385A (en) | Nasal drops for treating infant nasal obstruction | |
| CN102600343B (en) | Traditional Chinese medicinal preparation for treating oral diseases and/or toothache | |
| CN103638507A (en) | Traditional Chinese medicine compound for treating headache | |
| CN109646490A (en) | A kind of nine sesame oil and preparation method thereof for preventing and treating allergic rhinitis | |
| CN109453349A (en) | It is a kind of to ward off the cold, except tinea pedis lavipeditum Chinese herbal medicine bag and preparation method thereof | |
| CN103536673B (en) | Topical powder with strong enhanced immunity for removing food retention, bringing down fever and relieving cough and asthma, and application thereof | |
| CN103191247A (en) | Traditional Chinese medicine bag for stone needle ironing moxibustion | |
| CN103705556B (en) | One treats tetanic Chinese medicine composition | |
| RU10572U1 (en) | DEVICE FOR PREVENTION AND TREATMENT USING PHYTOPAROTHERAPY OF DISORDERS OF EXCHANGE PROCESSES OF VARIOUS ETHIOLOGY | |
| CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
| CN102204966B (en) | Traditional Chinese medicine liniment for external use for relaxing muscles and tendons and alleviating pain | |
| CN105902786A (en) | Traditional Chinese medicine for treatment of bronchitis | |
| CN106420340A (en) | Purple sand moxibustion chair | |
| CN106729011A (en) | A kind of topical composition | |
| CN105362774A (en) | Traditional Chinese medicine preparation for treating rabies | |
| CN107041912A (en) | A kind of Chinese medicine for configuring simple treatment onychomycosis | |
| CN103127301A (en) | Traditional Chinese medicine transdermal absorption administration carrier, traditional Chinese medicine clothes, and medicine clothes with disease control effect | |
| CN104013732A (en) | Soft capsules for treating rheumatoid diseases | |
| CN114762720A (en) | Moxa formula containing traditional Chinese medicine Tibetan medicine | |
| CN111481626A (en) | Medicine for preventing and treating infantile influenza A and preparation method thereof | |
| CN102600410A (en) | Externally applied traditional Chinese medicinal composition for treating bovine phthiriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHENYANG HONGQI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HUANG YING Effective date: 20091127 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20091127 Address after: Hunnan New District Shenyang city Liaoning province Luo Street No. 6 Patentee after: Shenyang Hongqi Pharmaceutical Co., Ltd. Address before: Tai'an traffic hospital, No.1 Yi Sheng Road, Shandong, Tai'an Patentee before: Huang Ying |
|
| CX01 | Expiry of patent term |
Granted publication date: 20050309 |
|
| CX01 | Expiry of patent term | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Zhuo Document name: Notice of expiration of patent right |
|
| DD01 | Delivery of document by public notice |